Literature DB >> 12213894

A minimal mathematical model of calcium homeostasis.

J F Raposo1, L G Sobrinho, H G Ferreira.   

Abstract

A mathematical model of calcium homeostasis is presented in which the controlling factors are the plasma concentrations of calcium, PTH, and calcitriol, and the effector organs are the parathyroids, bone, kidney, and intestine. Other factors can be added as the need arises. The model is aimed at simulating what happens in a single individual, but its parameters and variables were adjusted to the corresponding published average values. Simulations of published observations in humans undergoing the infusion of calcium or its chelators are presented. With a single exception, these simulations provided a good fit to the data. The response of the system to extrinsic perturbations was characterized by simulating chronic infusions of calcium, PTH, and calcitriol. Finally, the steady state response to perturbations in some of its parameters (the secretory mass of the parathyroids and the affinity and/or sensitivity of the calcium, PTH, and calcitriol receptors) and to renal failure were also investigated in an attempt to analyze the pathogenesis of clinical hypo- or hypercalcemias. In its present form the model cannot be used to base clinical decisions in individual cases. However, it requires modest computational resources, and clinicians with a modest mathematical background can manipulate it. It is a useful tool for the analysis of general mechanisms of the diseases of calcium metabolism and for the design of clinical experiments aimed at characterizing these diseases. The model can also be the core of future autoadaptive extensions to be used in individual patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213894     DOI: 10.1210/jc.2002-011870

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

Review 2.  Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.

Authors:  Jane P F Bai; Justin C Earp; Venkateswaran C Pillai
Journal:  AAPS J       Date:  2019-06-03       Impact factor: 4.009

Review 3.  Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.

Authors:  Donovan Tay; Serge Cremers; John P Bilezikian
Journal:  Br J Clin Pharmacol       Date:  2017-12-06       Impact factor: 4.335

4.  A mathematical model of calcium and phosphorus metabolism in two forms of hyperparathyroidism.

Authors:  J F Raposo; A Pires; H Yokota; H G Ferreira
Journal:  Endocrine       Date:  2011-08-27       Impact factor: 3.633

5.  Pharmacodynamic model of parathyroid hormone modulation by a negative allosteric modulator of the calcium-sensing receptor.

Authors:  Anson K Abraham; Tristan S Maurer; Amit S Kalgutkar; Xiang Gao; Mei Li; David R Healy; Donna N Petersen; David A Griffith; Donald E Mager
Journal:  AAPS J       Date:  2011-03-25       Impact factor: 4.009

6.  Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

Authors:  Hiroki Yokota; Ana Pires; João F Raposo; Hugo G Ferreira
Journal:  Gene Regul Syst Bio       Date:  2010-06-09

7.  Transient modulation of calcium and parathyroid hormone stimulates bone formation.

Authors:  Andy B Chen; Kazumasa Minami; João F Raposo; Nariaki Matsuura; Masahiko Koizumi; Hiroki Yokota; Hugo G Ferreira
Journal:  Endocrine       Date:  2016-08-08       Impact factor: 3.633

Review 8.  Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.

Authors:  Teun M Post; Serge C L M Cremers; Thomas Kerbusch; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

9.  Predicting nonlinear changes in bone mineral density over time using a multiscale systems pharmacology model.

Authors:  M C Peterson; M M Riggs
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-11-14

10.  Evaluation of the role of FGF23 in mineral metabolism.

Authors:  Hiroki Yokota; João F Raposo; Andy Chen; Chang Jiang; Hugo G Ferreira
Journal:  Gene Regul Syst Bio       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.